Literature DB >> 29173875

Emergence of Plasmodium falciparum triple mutant in Cambodia.

Gabriele Rossi1, Martin De Smet2, Nimol Khim3, Jean-Marie Kindermans4, Didier Menard5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29173875     DOI： 10.1016/S1473-3099(17)30635-7

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  12 in total

1.  Synthesis and Study of the Antimalarial Cardamom Peroxide.

Authors:  Xirui Hu; Pharath Lim; Rick M Fairhurst; Thomas J Maimone
Journal:  Tetrahedron       Date:  2018-03-26       Impact factor: 2.457

Review 2.  Multidrug-resistant malaria and the impact of mass drug administration.

Authors:  Janie Anne Zuber; Shannon Takala-Harrison
Journal:  Infect Drug Resist       Date:  2018-03-01       Impact factor: 4.003

Review 3.  Resistance to Artemisinin Combination Therapies (ACTs): Do Not Forget the Partner Drug!

Authors:  Christian Nsanzabana
Journal:  Trop Med Infect Dis       Date:  2019-02-01

4.  Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study.

Authors:  Rob W van der Pluijm; Mallika Imwong; Nguyen Hoang Chau; Nhu Thi Hoa; Nguyen Thanh Thuy-Nhien; Ngo Viet Thanh; Podjanee Jittamala; Borimas Hanboonkunupakarn; Kitipumi Chutasmit; Chalermpon Saelow; Ratchadaporn Runjarern; Weerayuth Kaewmok; Rupam Tripura; Thomas J Peto; Sovann Yok; Seila Suon; Sokunthea Sreng; Sivanna Mao; Savuth Oun; Sovannary Yen; Chanaki Amaratunga; Dysoley Lek; Rekol Huy; Mehul Dhorda; Kesinee Chotivanich; Elizabeth A Ashley; Mavuto Mukaka; Naomi Waithira; Phaik Yeong Cheah; Richard J Maude; Roberto Amato; Richard D Pearson; Sónia Gonçalves; Christopher G Jacob; William L Hamilton; Rick M Fairhurst; Joel Tarning; Markus Winterberg; Dominic P Kwiatkowski; Sasithon Pukrittayakamee; Tran Tinh Hien; Nicholas Pj Day; Olivo Miotto; Nicholas J White; Arjen M Dondorp
Journal:  Lancet Infect Dis       Date:  2019-07-22       Impact factor: 25.071

5.  No evidence of P. falciparum K13 artemisinin conferring mutations over a 24-year analysis in Coastal Kenya, but a near complete reversion to chloroquine wild type parasites.

Authors:  Kevin Wamae; Dorcas Okanda; Leonard Ndwiga; Victor Osoti; Kelvin M Kimenyi; Abdirahman I Abdi; Philip Bejon; Colin Sutherland; Lynette Isabella Ochola-Oyier
Journal:  Antimicrob Agents Chemother       Date:  2019-10-07       Impact factor: 5.191

6.  Novel anti-malarial drug strategies to prevent artemisinin partner drug resistance: A model-based analysis.

Authors:  Amber Kunkel; Michael White; Patrice Piola
Journal:  PLoS Comput Biol       Date:  2021-03-25       Impact factor: 4.475

7.  Clinical and In Vitro Resistance of Plasmodium falciparum to Artesunate-Amodiaquine in Cambodia.

Authors:  Melissa Mairet-Khedim; Rithea Leang; Camille Marmai; Nimol Khim; Saorin Kim; Sopheakvatey Ke; Chhayleang Kauy; Nimol Kloeung; Rotha Eam; Sophy Chy; Brigitte Izac; Denis Mey Bouth; Maria Dorina Bustos; Pascal Ringwald; Frederic Ariey; Benoit Witkowski
Journal:  Clin Infect Dis       Date:  2021-08-02       Impact factor: 9.079

8.  Efficacy and Safety of Pyronaridine-Artesunate plus Single-Dose Primaquine for the Treatment of Malaria in Western Cambodia.

Authors:  Rithea Leang; Nimol Khim; Huch Chea; Rekol Huy; Melissa Mairet-Khedim; Denis Mey Bouth; Maria Dorina Bustos; Pascal Ringwald; Benoit Witkowski
Journal:  Antimicrob Agents Chemother       Date:  2019-09-23       Impact factor: 5.191

9.  How to defuse malaria's ticking time bomb.

Authors:  Amy Maxmen
Journal:  Nature       Date:  2018-07       Impact factor: 49.962

10.  Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial.

Authors:  Rob W van der Pluijm; Rupam Tripura; Richard M Hoglund; Aung Pyae Phyo; Dysoley Lek; Akhter Ul Islam; Anupkumar R Anvikar; Parthasarathi Satpathi; Sanghamitra Satpathi; Prativa Kumari Behera; Amar Tripura; Subrata Baidya; Marie Onyamboko; Nguyen Hoang Chau; Yok Sovann; Seila Suon; Sokunthea Sreng; Sivanna Mao; Savuth Oun; Sovannary Yen; Chanaki Amaratunga; Kitipumi Chutasmit; Chalermpon Saelow; Ratchadaporn Runcharern; Weerayuth Kaewmok; Nhu Thi Hoa; Ngo Viet Thanh; Borimas Hanboonkunupakarn; James J Callery; Akshaya Kumar Mohanty; James Heaton; Myo Thant; Kripasindhu Gantait; Tarapada Ghosh; Roberto Amato; Richard D Pearson; Christopher G Jacob; Sónia Gonçalves; Mavuto Mukaka; Naomi Waithira; Charles J Woodrow; Martin P Grobusch; Michele van Vugt; Rick M Fairhurst; Phaik Yeong Cheah; Thomas J Peto; Lorenz von Seidlein; Mehul Dhorda; Richard J Maude; Markus Winterberg; Nguyen Thanh Thuy-Nhien; Dominic P Kwiatkowski; Mallika Imwong; Podjanee Jittamala; Khin Lin; Tin Maung Hlaing; Kesinee Chotivanich; Rekol Huy; Caterina Fanello; Elizabeth Ashley; Mayfong Mayxay; Paul N Newton; Tran Tinh Hien; Neena Valecha; Frank Smithuis; Sasithon Pukrittayakamee; Abul Faiz; Olivo Miotto; Joel Tarning; Nicholas P J Day; Nicholas J White; Arjen M Dondorp
Journal:  Lancet       Date:  2020-03-11       Impact factor: 202.731
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.